Rhythm Biosciences Limited
ASX:RHY.AX
0.1 (AUD) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|---|
Assets: | ||||||||
Current Assets: | ||||||||
Cash & Cash Equivalents
| 0.709 | 4.124 | 7.55 | 2.228 | 1.798 | 4.728 | 7.78 | 1.495 |
Short Term Investments
| 0.045 | 0.045 | 0.045 | 0.045 | 0.045 | 0.045 | 0.045 | 0 |
Cash and Short Term Investments
| 0.754 | 4.169 | 7.595 | 2.273 | 1.843 | 4.773 | 7.825 | 1.495 |
Net Receivables
| 0.037 | 0.066 | 0.082 | 0.164 | 0.139 | 0.798 | 0.035 | 0.004 |
Inventory
| 0.058 | 2.767 | 0 | 0 | 0 | 0 | 0 | -0.001 |
Other Current Assets
| 0.037 | 0.118 | 0.093 | 0.057 | 0.023 | 0.034 | 0.009 | 0.001 |
Total Current Assets
| 0.887 | 7.119 | 7.771 | 2.494 | 2.005 | 5.605 | 7.869 | 1.499 |
Non-Current Assets: | ||||||||
Property, Plant & Equipment, Net
| 0.278 | 0.186 | 0.241 | 0.114 | 0.143 | 0.09 | 0.009 | 0.004 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.354 | 0.39 | 0.426 | 0.462 | 0.498 | 0.534 | 0.57 | 0.05 |
Goodwill and Intangible Assets
| 0.354 | 0.39 | 0.426 | 0.462 | 0.498 | 0.534 | 0.57 | 0.05 |
Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 0 | 0 | 0 | -0 | 0 | 0 | 0 | -0.004 |
Total Non-Current Assets
| 0.632 | 0.576 | 0.667 | 0.576 | 0.641 | 0.624 | 0.579 | 0.05 |
Total Assets
| 1.519 | 7.695 | 8.438 | 3.07 | 2.646 | 6.229 | 8.449 | 1.549 |
Liabilities & Equity: | ||||||||
Current Liabilities: | ||||||||
Account Payables
| 0.212 | 1.334 | 0.278 | 0.603 | 0.561 | 0.207 | 0.079 | 0.049 |
Short Term Debt
| 0.078 | 0.085 | 0.086 | 0 | 0.042 | 0 | 0 | 0 |
Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 0.272 | 0.347 | 0.569 | 0.74 | 0.191 | 0.166 | 0.068 | 0.078 |
Total Current Liabilities
| 0.562 | 1.766 | 0.932 | 1.343 | 0.794 | 0.373 | 0.147 | 0.126 |
Non-Current Liabilities: | ||||||||
Long Term Debt
| 0 | 0 | 0.085 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.09 | 0.055 | 0.049 | 0.02 | 0.008 | 0.007 | 0.079 | 0 |
Total Non-Current Liabilities
| 0.09 | 0.055 | 0.133 | 0.02 | 0.008 | 0.007 | 0.079 | 0 |
Total Liabilities
| 0.652 | 1.821 | 1.066 | 1.363 | 0.803 | 0.38 | 0.147 | 0.126 |
Equity: | ||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 34.448 | 31.551 | 27.835 | 15.981 | 10.037 | 10.037 | 10.037 | 1.495 |
Retained Earnings
| -38.674 | -31.817 | -23.6 | -14.806 | -8.388 | -4.372 | -1.826 | -0.072 |
Accumulated Other Comprehensive Income/Loss
| 5.093 | 6.141 | 3.137 | 0.532 | 0.194 | 0.184 | 0.089 | 1.458 |
Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.458 |
Total Shareholders Equity
| 0.867 | 5.874 | 7.372 | 1.707 | 1.843 | 5.85 | 8.301 | 1.423 |
Total Equity
| 0.867 | 5.874 | 7.372 | 1.707 | 1.843 | 5.85 | 8.301 | 1.423 |
Total Liabilities & Shareholders Equity
| 1.519 | 7.695 | 8.438 | 3.07 | 2.646 | 6.229 | 8.449 | 1.549 |